Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma
Completed · Not applicable
Conditions studied: Renal Cell Carcinoma
In brief
Primary • To explore the use of OTL38 and fluorescence imaging to detect RCC in partial nephrectomy at the margins of resection, and in lymph node(s) or other metastases during radical nephrectomy.
Key facts
- Study ID
- NCT02645409
- Run by
- Chandru Sundaram
- People needed
- 14
- Starts
- 2015-12-29
- Expected to finish
- 2019-04-02
- Last updated by the study team
- 2020-02-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Indiana University Health Hospital — Indianapolis, Indiana, United States
- Indiana University Health Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.